Progresos y desafíos | 24 FEB 20

Diagnóstico de la esclerosis múltiple (en niños y adultos)

El diagnóstico de la esclerosis múltiple, los diferentes diagnósticos diferenciales, en especial otras enfermedades inflamatorias idiopáticas
Autor/a: Brownlee WJ, Hardy TA, FazekasF, Miller H Lancet.2017 Apr 1; 389(10076):1336-1346.
INDICE:  1. Página 1 | 2. Referencias bibiliográficas:
Referencias bibiliográficas:

1 Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria. Ann Neurol 2011; 69: 292–302.

2 Lublin FD, Reingold SC, Cohen JA, et al. Defi ning the clinical course of multiple sclerosis: the 2013 revisions. Neurology 2014; 83: 278–86.

3 Hirst C, Ingram G, Pickersgill T, Swingler R, Compston DA, Robertson NP. Increasing prevalence and incidence of multiple sclerosis in South East Wales. J Neurol Neurosurg Psychiatry 2009; 80: 386–91.

4 Wingerchuk DM, Banwell B, Bennett JL, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 2015; 85: 177–89.

5 Brownlee WJ, Miller DH. Clinically isolated syndromes and the relationship to multiple sclerosis. J Clin Neurosci 2014; 21: 2065–71.

6 Miller DH, Leary SM. Primary-progressive multiple sclerosis. Lancet Neurol 2007; 6: 903–12.

7 Off enbacher H, Fazekas F, Schmidt R, et al. Assessment of MRI criteria for a diagnosis of MS. Neurology 1993; 43: 905–09.

8 Fisniku LK, Brex PA, Altmann DR, et al. Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis. Brain 2008; 131: 808–17.

9 Fazekas F, Barkhof F, Filippi M, et al. The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis. Neurology 1999; 53: 448–56.

10 Sombekke MH, Wattjes MP, Balk LJ, et al. Spinal cord lesions in patients with clinically isolated syndrome: a powerful tool in diagnosis and prognosis. Neurology 2013; 80: 69–75.

11 Bot JC, Barkhof F, Lycklama a Nijeholt G, et al. Diff erentiation of multiple sclerosis from other infl ammatory disorders and cerebrovascular disease: value of spinal MR imaging. Radiology 2002; 223: 46–56.

12 Rovira A, Wattjes MP, Tintore M, et al. Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-clinical implementation in the diagnostic process. Nat Rev Neurol 2015; 11: 471–82.

13 Garg N, Reddel SW, Miller DH, et al. The corpus callosum in the diagnosis of multiple sclerosis and other CNS demyelinating and infl ammatory diseases. J Neurol Neurosurg Psychiatry 2015; 86: 1374–82.

14 Freedman MS, Thompson EJ, Deisenhammer F, et al. Recommended standard of cerebrospinal fl uid analysis in the diagnosis of multiple sclerosis: a consensus statement. Arch Neurol 2005; 62: 865–70.

15 Dobson R, Ramagopalan S, Davis A, Giovannoni G. Cerebrospinal fl uid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and eff ect of latitude. J Neurol Neurosurg Psychiatry 2013; 84: 909–14.

16 Leocani L, Comi G. Clinical neurophysiology of multiple sclerosis. Handb Clin Neurol 2014; 122: 671–79.

17 Negrotto L, Tur C, Tintore M, et al. Should we systematically test patients with clinically isolated syndrome for auto-antibodies? Mult Scler 2015; 21: 1802–10.

18 Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13: 227–31.

19 Brownlee WJ, Swanton JK, Altmann DR, Ciccarelli O, Miller DH. Earlier and more frequent diagnosis of multiple sclerosis using the McDonald criteria. J Neurol Neurosurg Psychiatry 2015; 86: 584–85.

20 Montalban X, Sastre-Garriga J, Filippi M, et al. Primary progressive multiple sclerosis diagnostic criteria: a reappraisal. Mult Scler 2009;15: 1459–65.

21 Liu S, Kullnat J, Bourdette D, et al. Prevalence of brain magnetic resonance imaging meeting Barkhof and McDonald criteria for dissemination in space among headache patients. Mult Scler 2013;19: 1101–05.

22 Nielsen JM, Korteweg T, Barkhof F, Uitdehaag BM, Polman CH. Overdiagnosis of multiple sclerosis and magnetic resonance imaging criteria. Ann Neurol 2005; 58: 781–83.

23 Selchen D, Bhan V, Blevins G, et al. MS, MRI, and the 2010 McDonald criteria: a Canadian expert commentary. Neurology 2012;79: S1–15.

24 Absinta M, Rocca MA, Colombo B, et al. Patients with migraine do not have MRI-visible cortical lesions. J Neurol 2012; 259: 2695–98.

25 Montalban X, Tintore M, Swanton J, et al. MRI criteria for MS in patients with clinically isolated syndromes. Neurology 2010;74: 427–34.

26 Patrucco L, Rojas JI, Miguez JS, Cristiano E. Application of the McDonald 2010 criteria for the diagnosis of multiple sclerosis in an Argentinean cohort of patients with clinically isolated syndromes. Mult Scler 2013; 19: 1297–301.

27 Huh SY, Kim SH, Kim W, et al. Evaluation of McDonald MRI criteria for dissemination in space in Korean patients with clinically isolated syndromes. Mult Scler 2014; 20: 492–95.

28 Okuda DT, Mowry EM, Beheshtian A, et al. Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome. Neurology 2009; 72: 800–05.

29 Okuda DT, Siva A, Kantarci O, et al. Radiologically isolated syndrome: 5-year risk for an initial clinical event. PLoS One 2014;9: e90509.

30 Lebrun C, Bensa C, Debouverie M, et al. Association between clinical conversion to multiple sclerosis in radiologically isolated syndrome and magnetic resonance imaging, cerebrospinal fluid, and visual evoked potential: follow-up of 70 patients. Arch Neurol 2009; 66: 841–46.

31 Giorgio A, Stromillo ML, Rossi F, et al. Cortical lesions in radiologically isolated syndrome. Neurology 2011; 77: 1896–99.

32 Krupp LB, Tardieu M, Amato MP, et al. International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 defi nitions. Mult Scler 2013; 19: 1261–67.

33 Chabas D, Castillo-Trivino T, Mowry EM, Strober JB, Glenn OA, Waubant E. Vanishing MS T2-bright lesions before puberty: a distinct MRI phenotype? Neurology 2008; 71: 1090–93.

34 Peche SS, Alshekhlee A, Kelly J, Lenox J, Mar S. A long-term follow-up study using IPMSSG criteria in children with CNS demyelination. Pediatr Neurol 2013; 49: 329–34.

35 Sadaka Y, Verhey LH, Shroff MM, et al. 2010 McDonald criteria for diagnosing pediatric multiple sclerosis. Ann Neurol 2012; 72: 211–23.

36 Tremlett H, Devonshire V. Is late-onset multiple sclerosis associated with a worse outcome? Neurology 2006; 67: 954–59.

37 de Seze J, Delalande S, Michelin E, et al. Brain MRI in late-onset multiple sclerosis. Eur J Neurol 2005; 12: 241–44.

38 Wallner-Blazek M, Rovira A, Fillipp M, et al. Atypical idiopathic infl ammatory demyelinating lesions: prognostic implications and relation to multiple sclerosis. J Neurol 2013; 260: 2016–22.

39 Seewann A, Enzinger C, Filippi M, et al. MRI characteristics of atypical idiopathic infl ammatory demyelinating lesions of the brain: A review of reported fi ndings. J Neurol 2008; 255: 1–10.

40 Lucchinetti CF, Gavrilova RH, Metz I, et al. Clinical and radiographic spectrum of pathologically confi rmed tumefactive multiple sclerosis. Brain 2008; 131: 1759–75.

41 Hardy TA, Reddel SW, Barnett MH, Palace JDM, Lucchinetti CF, Weinshenker BG. Atypical infl ammatory demyelinating syndromes of the CNS. Lancet Neurol 2016; 15: 967–81.

 

Comentarios

Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

AAIP RNBD
Términos y condiciones de uso | Política de privacidad | Todos los derechos reservados | Copyright 1997-2024